M

Maze Therapeutics Inc
NASDAQ:MAZE

Watchlist Manager
Maze Therapeutics Inc
NASDAQ:MAZE
Watchlist
Price: 38.86 USD -1.79% Market Closed
Market Cap: 1.9B USD

Wall Street
Price Targets

MAZE Price Targets Summary
Maze Therapeutics Inc

Wall Street analysts forecast MAZE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAZE is 44.12 USD with a low forecast of 34.34 USD and a high forecast of 63 USD.

Lowest
Price Target
34.34 USD
12% Downside
Average
Price Target
44.12 USD
14% Upside
Highest
Price Target
63 USD
62% Upside
Maze Therapeutics Inc Competitors:
Price Targets
NAVA
Navamedic ASA
46% Upside
MARKSANS
Marksans Pharma Ltd
23% Upside
IPCALAB
IPCA Laboratories Ltd
9% Upside
UCB
Ucb SA
9% Upside
195940
HK Inno.N Corp
26% Upside
DPHARMA
Duopharma Biotech Bhd
39% Upside
TBPH
Theravance Biopharma Inc
50% Upside

Revenue
Forecast

Revenue Estimate
Maze Therapeutics Inc

The compound annual growth rate of Maze Therapeutics Inc's revenue for the next 4 years is -27%.

N/A
Past Growth
-27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Maze Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Maze Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MAZE's stock price target?
Price Target
44.12 USD

According to Wall Street analysts, the average 1-year price target for MAZE is 44.12 USD with a low forecast of 34.34 USD and a high forecast of 63 USD.

What is Maze Therapeutics Inc's Revenue forecast?
Projected CAGR
-27%

The compound annual growth rate of Maze Therapeutics Inc's revenue for the next 4 years is -27%.

Back to Top